Phase II Study of Sunitinib (SU) in Japanese Patients with Well-Differentiated Pancreatic Neuroendocrine Tumor (NET)

Authors :: Hisato Igarashi
Toshirou Nishida
Masayuki Imamura
A. Sawaki
Kenji Yamao
Satoshi Hashigaki
Takamichi Ito
Nobuyuki Kimura
Emiko Ohki
Takuji Okusaka
Source :: Annals of Oncology. 24:ix82
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: Oncology
medicine.medical_specialty
Pancreatic neuroendocrine tumor
Sunitinib
business.industry
Internal medicine
medicine
Hematology
medicine.disease
business
Well differentiated
medicine.drug

Full Text Access

Tools